Opinions on the use of technology to improve tablet taking in >65-year-old patients on cardiovascular medications. by Holender, Anita et al.
Clinical Report
Opinions on the use of
technology to improve
tablet taking in >65-year-old
patients on cardiovascular
medications
Anita Holender1, Stephen Sutton1 and
Anna De Simoni2
Abstract
Objective: This study was performed to evaluate the perceptions of the use of technology to
improve cardiovascular medicine taking among patients aged >65 years.
Methods: This qualitative study used focus groups with people aged >65 years taking cardio-
vascular medications from two East London community centres. Thematic analysis was informed
by the Perceptions and Practicalities Approach framework.
Results: Participants welcomed technologies they considered familiar, accessible, and easy
to use. They valued the opportunity to receive alerts to help with forgetting and monitoring
their treatment. More advanced technologies such as ingestible sensor systems were considered
helpful for elderly people with significant cognitive impairments still living in the community
because of improved monitoring by caregivers and clinicians and prolonging independence.
Although generally adapting to the increase in technology in everyday life, participants raised a
number of concerns that included potential reduction in face-to-face communication, data secu-
rity, becoming dependent on technology, and worrying about the consequences of technologi-
cal failure.
Conclusions: Participants raised a number of concerns and practical barriers that would need to
be addressed for technologies to be accepted and adopted in this patient group.
1Primary Care Unit, Institute of Public Health, University
of Cambridge School of Clinical Medicine, Cambridge, UK
2Centre for Primary Care and Public Health, Barts and
The London School of Medicine and Dentistry, Yvonne
Carter Building, QMUL, London, UK
Corresponding author:
Anna De Simoni, Centre for Primary Care and Public
Health, Barts and The London School of Medicine and
Dentistry, Yvonne Carter Building, QMUL, London E1
2AB, UK.
Email: a.desimoni@qmul.ac.uk
Journal of International Medical Research
0(0) 1–15
! The Author(s) 2018
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0300060518770578
journals.sagepub.com/home/imr
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/)
which permits non-commercial use, reproduction and distribution of the work without further permission provided the original
work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords
Adherence, technology, digital interventions, >65 years old, cardiovascular medications,
focus group
Date received: 1 December 2017; accepted: 22 March 2018
Background
Good adherence to cardiovascular medica-
tions decreases the incidence of adverse car-
diovascular events.1,2 However, the World
Health Organization estimates that 50% of
patients do not take their medications as
prescribed.3 Studies have shown that adher-
ence is generally poor across many cardio-
vascular drug classes.4 Approximately 9%
of cardiovascular events can be associated
with poor medication adherence, while
good adherence can be associated with a
20% lower risk of cardiovascular disease
and a 35% reduced risk of all-cause mortal-
ity.5 Although adherence improves with
increasing age6 and adults aged >65 years
show better adherence to cardiovascular
medications than younger patients,7 older
patients are more likely to have chronic ill-
nesses and take more prescription medica-
tions.8 Therefore, interventions to improve
medication adherence among patients of
this age range are warranted.
Numerous technologies using mobile
phones and smartwatches9 exist to aid
patients with tablet taking and may addi-
tionally be used to monitor adherence.10
Mobile applications allow patients to
receive counselling about medications and
reminders to improve and monitor tablet
taking. Apps have been effective in increas-
ing adherence to antidepressants,11 while
interactive text message reminders and
other automated telecommunication inter-
ventions for tablet taking have improved
medication adherence12,13 and clinical out-
comes such as systolic blood pressure.14
Ingestible sensor systems (ISSs) are a combi-
nation of wearable and ingestible sensors
working in conjunction with mobile phones,
personal computers (PCs), or touchscreen
tablets to detect ingested medication.15,16
These technologies aid not only the
patient but also healthcare professionals
and family members involved in the patient’s
care thanks to the option of data sharing.10
The use of technology in everyday life
among people aged 65 years is increasing.
In the UK, approximately 89% of adults
use the Internet, and users aged 65 to
74 years increased from 52% to 78% in
2011.17 Approximately 42% of people of
all genders aged 75 years are now
Internet users.18 Nevertheless, a significant
proportion of the >65-year-old population
remains unfamiliar with technology, and
physical and mental impairments might
make it difficult to accept and adopt tech-
nology in everyday medication taking.
Moreover, the nature of electronic informa-
tion about personal medication taking
raises concerns regarding privacy and data
security.19,20 Acceptability of the available
technologies to help with tablet taking in
people aged >65 years and privacy and eth-
ical concerns21 are important factors to
consider when designing digital healthcare
interventions.
However, we found a paucity of qualita-
tive studies investigating opinions about
available technologies to help with medica-
tions in patients aged >65 years taking
cardiovascular medications. Qualitative
studies21–23 have tended to focus on barriers
2 Journal of International Medical Research 0(0)
to the use of a specific technology and as
such have not considered the full range of
nuanced opinions on these technologies in
the context of daily tablet taking.
Therefore, the aim of this study was to eval-
uate >65-year-old patients’ opinions on dig-
ital interventions to improve tablet taking
delivered through smartphone, smartwatch,
and ISS technologies using a theoretical
framework that allows identification of prac-
tical and perceptual barriers.
Methods
Ethical approval
Ethical approval was granted by Queen
Mary University Ethics of Research
Committee (QMERC1476a).
Setting
The present study involved two focus
groups.24 The focus groups were organised
in the context of gathering patient and
public involvement data for a research
grant application aimed at improving adher-
ence to antihypertensive medications through
digital interventions in primary care, recruit-
ing patients from East London. Because
many patients with hypertension are >65
years old, we gathered opinions from this
patient group regarding whether technology
can play a role in improving the way they
take their medications. The focus groups
were conducted in two East London commu-
nity centres: the Southern Grove Community
Centre knitting group and the Bromley-by-
Bow Community Centre Healthy Lifestyle
group. Recruitment was opportunistic,
and convenience sampling was applied.
Each group comprised six participants. The
inclusion criteria were an age of >65 years
and taking cardiovascular medications
(antihypertensive, antiplatelet, anticoagulant,
cholesterol-lowering, or type 2 diabetes
medications).
The focus groups took place immediately
after the community activity on the centre
premises and were facilitated by a general
practitioner (GP) and clinical lecturer
(A.D.S.) with expertise in qualitative meth-
odologies. A.D.S. worked as a GP in a
different UK region and was not part of
the participants’ care team. The focus
group approach was chosen over other
qualitative methods (e.g., interviews) as a
way of capturing the profiles of a variety
of participants and giving each participant
a chance to exchange viewpoints and discuss
disagreements. All participants provided
written informed consent to participate in
the study and for their anonymised quotes
to be published. Discussions were prompted
by printout images of a mobile phone/
smartphone, a smartwatch, and an ISS.
The focus group topic guide included
three main questions: Do you think tech-
nologies could be helpful in improving the
way you take your medications? What are
the advantages, disadvantages, and practi-
calities of these technologies? What are the
advantages and disadvantages of electroni-
cally monitoring your own medicine taking
and of sharing these data with family mem-
bers and healthcare professionals?
Both groups were shown all of the tech-
nologies and spent different lengths of time
discussing them.
Information was collected about age;
cardiovascular medications; ethnicity;
access to a smartphone, PC, or touchscreen
tablet; and access to the Internet at home.
Analysis
Recordings were transcribed by The Typing
Works, a transcription service.25 The tran-
scription was independently analysed by
A.D.S. and A.H. using thematic analysis.26
The Perceptions and Practicalities
Approach (PAPA) framework27 was used
to aid classification of emerging themes
into barriers and facilitators to the use of
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technology in tablet taking. The PAPA
framework provides a theoretical framework
to understand adherence to medications
based on the overlapping categories of inten-
tional and unintentional non-adherence. The
Necessity-Concerns Framework was used in
this study to show how concerns about using
technologies to help with daily tablet taking
can be influenced by judgements of personal
need for the technologies and concerns
about their potential adverse consequences.
A.D.S. and A.H. compared their classifica-
tion of themes according to the PAPA
framework. There were few discrepancies,
which were primarily semantic and resolved
through discussion.
Results
Participants
Twelve participants took part in two focus
groups in 2015. The participants were
similar with respect to age range and
medications taken, although there were dif-
ferences in gender, ethnicity, and the use of
technology in day-to-day life (see Table 1).
The first focus group was a knitting group
comprising white British women. The partic-
ipants had WiFi access at home, and all but
one owned a smartphone; this participant
had access to an iPad. The second focus
group was a health and fitness group from
Tower Hamlets comprising two women and
four men; three participants were white
British individuals and three were South
Asian. Only one participant in the second
focus group owned a smartphone and had
WiFi access at home.
Themes
Various themes regarding barriers to and
facilitators of the use of technology to
help with daily medication taking emerged
in this study (Table 2).
Table 1. Participants’ characteristics.
Focus
group M/F
Age,
years Medications
Smartphone,
PC, or touchscreen
tablet user
Home
WiFi access
1 F 65 Blood pressure, cholesterol tablets Yes Yes
1 F 72 Cholesterol tablets Yes Yes
1 F 76 Blood pressure, cholesterol, antiplatelet/
anticoagulant tablets
Yes Yes
1 F 69 Blood pressure, cholesterol tablets Yes Yes
1 F 75 Blood pressure, cholesterol tablets Yes Yes
1 F 73 Cholesterol tablets Yes Yes
2 F 71 Blood pressure, cholesterol, type 2
diabetes tablets
No No
2 F 73 Blood pressure, cholesterol, antiplatelet/
anticoagulant tablets
No No
2 M 66 Cholesterol tablets Yes Yes
2 M 67 Blood pressure, cholesterol, type 2
diabetes tablets
No No
2 M 75 Cholesterol tablets No No
2 M 67 Blood pressure, antiplatelet/anticoagulant,
type 2 diabetes tablets
No No
M, male; F, female; PC, personal computer
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Table 2. Opinions on the use of technology to improve tablet taking in people aged >65 years.
BARRIERS FACILITATORS
Themes Practicalities Capability and resources
Familiarity • Lacking familiarity
with technology
• Welcoming technology when
familiar (e.g., through a smart-
phone or watch)
Accessibility • Worrying about accessibility
(is technology easily available
to use when needed?)
• Memory problems can affect
medicine taking despite the use
of technology
Alerting/Monitoring • Seeing technology as memory
aids through alerts/reminders
• Improving medication monitor-
ing by the care team
• Real-time monitoring may pre-
vent adverse events
Technology and use of health-
care resources
• Seeing technology as expensive
in terms of costs and healthcare
professionals’ time
• Seeing technology as a way of
maximising resources
Technology and cognitive
impairments
• Experiencing significant cognitive
impairments affects capability to
both take medicines and
use technology
• Advanced technologies (such as
ISS) that require no technical
expertise from patients and lim-
ited input by caregivers, such as
charging batteries
Perceptions Necessity beliefs and concerns
Necessity Beliefs
Presence of technology in
everyday life
• Adapting to the increase in
technology in everyday life
Importance of adherence to
medications
• Thinking that cardiovascular
medications are not necessary
• Believing that taking cardiovas-
cular tablets is an essential
daily activity
Concerns
• Thinking that technology reduces
communication; impersonal
• Worrying about technologi-
cal failures
• Worrying about data security
and privacy
• Worrying about dependence on
others and on technology itself
• Thinking that technology reduces
confusion with polypharmacy
• Thinking that technology
improves accountability to care
team and to self
• Being reassured by technology-
linked dependence on others
rather than self
• Thinking that technology pro-
longs independence
Themes are divided into barriers and facilitators according to the PAPA framework.27
ISS, ingestible sensor system
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The findings are presented within the fol-
lowing two main groups according to the
PAPA framework:
1. Practical factors related to using technol-
ogy with daily tablet taking (practicalities)
2. Beliefs about using technology with daily
tablet taking (i.e., doubts about personal
need for technology) and motivational
factors (i.e., concerns about the technol-
ogies themselves)
Practicalities
Familiarity with technology. The extent to
which individuals were familiar with a
given technology had an impact on their
attitudes toward using it in relation to
taking medication.
Participants in the first focus group were
accustomed to receiving phone reminders
about healthcare appointments, had an
understanding of mobile technology, and
welcomed the idea of interventions through
text messaging or phone alerts/reminders.
I mean it’s a similar thing with now that
hospitals, they text you to remind you
about your hospital appointment now [FG1].
Participants in the second focus group were
not familiar with smartphones, but all used
wristwatches and preferred interventions
using this technology, such as smartwatches.
. . .watches, if we all had watches. . .
If it’s simpler to use elderly would appreci-
ate more, it’s something that they have on
their hand, on their arm. . .
It’s a continuation of what we’re familiar
with instead of something that we’re not
familiar [FG2].
Participants in both focus groups felt that
those least familiar with technology would
be the older, more vulnerable part of the pop-
ulation. Interestingly, they were also felt to be
those who in theory would benefit most from
the technology, thus negating its benefit.
A lot of older people who are 70 plus, 80s,
90s who are not going to have this technol-
ogy, they’re not going to have, and it’s them
people that are probably on the medication
and it’s more vital that they use the medi-
cation [FG1].
95% of it I set up myself ‘cos I’m fine with
it now, I get my emails on the phone and
send emails but you’re not going to get
elderly people [FG1].
Nevertheless, the participants recognised
that over time this will become less of a
problem as the population as a whole
becomes more familiar with technology.
Are you planning to keep using your smart-
phone and your internet access for the rest
of your life? Yeah, I’m a man of the 21st
century. . .[FG2].
I mean we use things [technology] when
we’re doing our exercises to see how well
we’re doing, I mean that’d only be the
same kind of thing just to do with taking
tablets [FG2].
Accessibility: technology readily available when
needed. The ability to use different technol-
ogies varied throughout the population.
Accessibility of technologies to users was
identified as an important issue.
For example, some elderly people do not
carry mobile phones with them at all times;
they are more likely to wear a wristwatch,
which is less likely to be left somewhere
and forgotten.
The watch is good but the mobile phone,
half the time old people don’t know where
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they’ve put the phone, it’s the same with
glasses, they don’t know where they’ve put
them so it wouldn’t be of no benefit, but that
watch would [FG2].
Owning a phone does not necessarily imply
easy accessibility to an intervention being
delivered through it.
. . .a smartphone, well, I did have but I put it
in the washing machine, I dropped
it [FG2].
Moreover, while a technology may be
familiar to a person, this does not necessar-
ily mean it is easy to use or accessible to
them. The participants in the health and
fitness focus group were given pedometers
as part of their programme. Some found the
pedometers to be too complicated.
You’re using a pedometer so you are
already doing something.
Yeah, but I found it very difficult using
it. . . [FG2].
. . .Well I’m not being funny and I’m not
being rude but we’re in Tower Hamlets
and a lot of people are not really well edu-
cated to be doing these smartphones, some
are, but a lot of older people. . . [FG2].
Technology as memory aid. One of the major
perceived benefits of using technology to
improve tablet taking was its use as a
memory aid. Participants recognised that
forgetting to take medications was a signif-
icant problem that would only increase
with age.
I think it’s good because there’s some
people who as time goes by lose certain of
their faculties as time goes by, and memory
beginning to fade and so on, so on, it could
have been a short retention in memory can
cause you to miss a [medicine]. . . [FG2].
Even participants with a routine or a system
to remember tablets, such as calendar packs,
acknowledged being susceptible to occasion-
al lapses in memory and saw the benefit of
prompting tablet-taking through technology.
. . .you always need to remember these
things, they do slip your mind, even if
there’s days of the week printed on your
tablets sometimes you think, “did I take it
this morning?” [FG2].
Interestingly, participants highlighted that
memory problems could negatively impact
the use of technology (e.g., by forgetting to
charge or check a device) just like they
affected medication taking in the first place.
If they’re not going to remember to take
their tablets they ain’t going to remember
to charge their mobiles [FG1].
Technology can improve monitoring by care
team. The storage of patient data through
technology offers healthcare teams and
carers the opportunity of being able to
access patients’ records of medication
taking and therefore better monitor the
patients’ medicine taking.
I think you know, technology is getting
better, I mean my doctor can access any-
thing, . . ..he can access it from his computer
and the hospital Consultant, he’s able to
have access to that information, I think
that is useful [FG2].
I think it’s a wonderful idea, because they’re
being checked and they’re being monitored
aren’t they? [FG1].
A practical advantage of regular monitor-
ing was the immediacy with which
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information can reach healthcare professio-
nals and therefore the potential for identi-
fying problems before they become too
harmful; e.g., regularly missing important
medications or accidentally overdosing.
. . .[talking about a common acquaintance
who is struggling taking medications]
. . .that would have helped, they would
have known that she . . .was not taking
that[medicine][FG1].
Technology and the use of resources.
Participants showed awareness of the scar-
city of resources in healthcare, both in
terms of the economic costs of technology
itself and its implementation, and the time
that healthcare professionals spent moni-
toring collected data. Elderly people consti-
tute a small proportion of smartphone
owners, although they represent the popu-
lation who would benefit most from this
technology in terms of help with tablet
taking. Making it accessible to them was
felt to involve a significant financial outlay.
If it’s got to be a smart phone rather than
an ordinary phone the cost of providing
these for all the elderly is going to be astro-
nomical [FG1].
Those who regularly struggle with their
tablet-taking would be picked up by the
technology, but this may create more
work for healthcare professionals because
all reports generated by the technology
will need to be seen by both healthcare pro-
fessionals and carers. This was perceived as
inefficient use of professional time.
So every time this person gets their tablets
wrong and makes a mistake, the GP is
informed practically every day or a family
member that they haven’t taken their tab-
lets properly. . ..
And how on earth would GPs have the
time [FG1].
However, the participants recognised that
while the immediate cost might be high,
the benefits of regular medication reminders
and monitoring could save unnecessary
input from being sent to healthcare profes-
sionals and even prevent adverse clinical
events, thus making it cost-effective overall.
So if. . .that’s sent out to you and you took
all your medication, the GP wouldn’t see
you so much would he, it’d cut that bit
down wouldn’t it? [FG2].
Patients with significant impairments are the main
beneficiaries of ISS technology. Participants
recognised that in cases of poor medication
adherence caused by reduced mental capac-
ity or cognitive function, technology was
unlikely to make a difference.
For somebody that’s completely compos
mentis I’d say brilliant, but we’re not talk-
ing about those sort of people are
we? [FG1].
For patients with cognitive impairments or
severe disability, the ISS was identified as
the most useful technology because of the
potential real-time identification
of problems.
[Through using the ISS] someone like
Paula [name changed to preserve anonym-
ity] would flag up straightaway wouldn’t
she, that she doesn’t know what she’s
doing [FG1].
I think it’s a wonderful idea, because they’re
being checked and they’re being monitored
aren’t they? [FG1].
The ISS seemed simple enough that,
once set up, a minimal understanding of
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technology was needed to use it; this could
appeal to those not particularly comfort-
able with technologies.
That technology of actually ingesting a tab-
let. . . that’s all you’d need to do and it
would send a message to those who receive
it to the server and they’re able to monitor
. . .you wouldn’t find it helpful?
It might prolong independence, people’s
independence. . . [FG2].
The benefit of ISS technology will be less
important where high-level monitoring is
available, such as in a care home.
Most probably it won’t be useful in homes
and all that, care homes. . . [FG2].
Perceptions
Necessity
Presence of technology in everyday life.
Individuals’ beliefs regarding necessity deter-
mine whether they feel technology is neces-
sary for improving their medication taking.
The participants stated that technology
is becoming an ever-larger part of everyday
life, is becoming essential for increasingly
more people over time, and will become
more prominent in healthcare. As the
more technology-literate generations age,
the elderly population will become more
used to technology in the context of a
daily activities such as medicine taking.
Now these things are being used more the
older people will get used to them [FG1].
Necessity of technology to help with daily med-
ication taking. Interestingly, while many par-
ticipants considered that the use of
technology to improve tablet taking was
beneficial and even necessary for some
people, most felt that they would not
make use of it. They felt that technologies
would be necessary for someone ‘worse’
than them.
I like to stay with some technology, so if
there’s an appropriate App of course then
I’ll use it accordingly you know, not for the
sake of using it but if it’s appropriate then I
will use it [FG2].
This was particularly true of ISS technology.
I haven’t got a problem with it, it’s just that
I don’t think I take sufficient tablets and I
do take them regularly [FG1].
Importance attributed to taking medication.
Most participants recognised that consider-
ing medication taking to be important
would strengthen their beliefs regarding
the necessity of the use of technology.
You always need to remember these things,
they do slip your mind, even if there’s days
of the week printed on your tablets some-
times you think, “Did I take it this
morning?” [FG2].
The participants also acknowledged that
some people intentionally fail to take their
tablets because of motivation issues. The
participants felt that technology is unlikely
to help improve tablet taking in these cir-
cumstances and that these patients will
likely not consider technology for their
medication taking.
. . .Because like yeah, they [think that med-
ications] are not doing them good
You can’t force someone to take tablets if
they don’t want them
. . .or I mean a lot of them collect them but
then they don’t take them [FG2].
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Participants in the first focus group dis-
cussed the issue of elderly people with signif-
icant physical and cognitive impairments
who no longer wish to live and believe that
medications are no longer needed. Although
in theory they may be helped with tablet
taking by technology, they might not wish
to engage with it. In these cases, technology
cannot be forced upon them.
A lot of people haven’t got anything to
carry on for, so you can’t force somebody
can you? [FG1].
Concerns
Technology and patient–professional
communication. A concern voiced by partic-
ipants was that distance monitoring of
tablet taking through technology can
reduce the frequency of healthcare profes-
sionals’ visits to patients or that their inter-
actions may become somehow impersonal.
Patients could be at risk of receiving less
face-to-face care, in turn making the elderly
more vulnerable.
Well I see [technology might cause] lack of
communication between professionals and
the very elderly. . .., I’m afraid that this is
about cost-cutting [FG1].
Technology and patients’ accountability to the care
team and to self. Participants felt that if they
knew they were being monitored, they
would be more accountable for their tablet
taking and that this would encourage them
to take their medication. Furthermore,
greater involvement of the care team or
their family support network would con-
tribute to holding them accountable.
. . .that goes to your GP or a family
member; they will know that you have
been taking it [FG1].
The health and fitness focus group com-
pared the proposed technologies to their
existing pedometers and saw benefits in
being held more accountable not only to
their care team but also to themselves
because this increased self-awareness
would have a positive impact on their
daily routines.
I think they work; they do make you aware
of what you’re doing [FG2].
At the same time, however, the participants
acknowledged the risk that the technology
would delegate the responsibility of tablet
taking to family members and the care
team rather than the patients themselves.
But that would literally stop you thinking
wouldn’t it, you’d think, “oh well, they’ll
know up the surgery whether I took it or
not” [FG2].
Potential technological failures. The second
focus group was particularly wary of
making technology a large feature of their
lives and described how past high-profile
failures of the implementation of technolo-
gy in healthcare have had a significant neg-
ative impact on people’s confidence in
technology. As such, they were reluctant
to completely trust in or depend on it.
You see this is in an ideal world, I remember
there was, the National Health Service
right, had invested billions into this high
tech computer that was going to be doing
all singing all dancing, and guess what, it
never did work, so all the investment that
they put into this main frame that would
then take all the information, it had gone
done, it had a bug, it had glitches and it
never performed as fit for purpose, so I’m
one of these guys who’s lost confidence in
technology [FG2].
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Moreover, technology itself could fail if, for
example, it was not maintained properly.
.It’s not fail proof is it, no.
.So it’s not so much emphasis on what it can
do, what happens when it doesn’t do what it
should be doing, then what happens next, is
there a plan b? [FG2].
. . .I’m really sold on the watch, but. . .but
there is some disadvantages, there’s going
to be a point where you need to put in new
lithium battery. . .[FG2].
Technology is useful but you can’t depend
on it, you never can depend on it . [FG2].
Security concerns. Medication monitoring
through technology was seen as more sus-
ceptible to misuse than was face-to-face
healthcare. Some participants expressed
concerns about the safety of their data
and the possibility of their whereabouts
being tracked through technology.
And I just think when we pick our phone up
people know exactly where we are
don’t they?
. . .if you turn the location off on your phone
then they can’t put, then they can’t find
you. . . [FG1].
Dependence on others and on technology versus
independence. A concern that emerged in
discussion was the reluctance to become
dependent on either other people or tech-
nology because both are fallible, and
over-dependence could cause significant
problems when technology or the chain of
communication fails.
Just to give you an example, . . . there’s
some people who’ll be told use a walking
stick and then you rely on the walking
stick so much then you can’t take it from
them, and some people says, “I’ll only use it
somewhere down the line, thank you for
your advice but I won’t, I’ll struggle
on”. . .But some people you offer them a
walking stick, they can’t even get out the
bed without it, so the question is to find a
balance [FG2].
However, participants also recognised that
receiving assistance with medications
through technology would potentially be
beneficial by allowing people to look after
themselves better, reducing the need for
carers or admission to care homes, thus pro-
longing independence with minimal support.
It might prolong independence, people’s
independence, . . .on a daily basis as right,
this is just what I need to do. . . [FG2].
Others found that the opportunity to
depend on someone else would be beneficial
and bring peace of mind.
If you think it’s going to help you and
you’re relieved that, you know, someone’s
going to help you take your medication I
think there’s far more people going to be
like that [FG1].
Participation in studies that test technology to help
with medicine taking. When asked about their
willingness to enrol in a study testing any of
the technologies, the participants generally
replied positively, although there were differ-
ences between the two focus groups. While
the first group welcomed participating in
studies using technologies such as smart-
phones, touchscreen tablets, and smart-
watches, the second group clearly indicated
they would accept smartwatches only.
Everybody’s been used to wearing at some
time or another is a watch. . . [FG2].
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. . .So I think . . .from our little sampling
survey of 6 of us, that most of us would
find this much better. . . [FG2].
In relation to the ISS, participants in the
first focus group stated that they would
enrol in a study provided that they were
reassured about its safety, while partici-
pants in the other group felt that the tech-
nology was too unfamiliar to consider it.
Both groups asked questions about safety
issues and any adverse events documented
in previous studies.
Have you already done human trials?
And they’ve had no adverse effects?. . .
What happens when you have a bath?
I would be willing to do it but if I had it
checked out that it wouldn’t interfere with
whatever else I’m taking [FG1].
. . .has it been tested in Sweden, has it been
tested in Denmark, was there a model that
you can follow or are you the front runners,
the pathfinders, where are we in the technol-
ogy? [FG2].
Discussion
We have herein described facilitators of and
barriers to the use of technology (specifically
through mobile phones, PCs, touchscreen
tablets, smartwatches, and the ISS) to
improve tablet taking in people aged >65
years on cardiovascular medications using
the PAPA framework. Acknowledging and
addressing these factors can facilitate the
design of digital interventions for this patient
group and their recruitment to studies.
Participants welcomed the idea of tech-
nologies as memory aids and as a means of
monitoring medication taking. Familiarity
and accessibility were key factors for
accepting technology. Being affected by sig-
nificant cognitive impairments was seen as
an important practical barrier for which
technology such as the ISS had potential
to help.
Some participants saw technology as an
unnecessary expense, while others consid-
ered it to be a way of maximising scarce
resources and improving patients’ indepen-
dence. Similarly, some were worried about
being overly dependent on the technology,
while others thought it provided them with
reassurance.
Strengths and limitations
The strength of this work lies in the open
nature of the discussions on digital inter-
ventions through multiple technologies.
These opinions may not be captured by
studies focusing on specific digital interven-
tions or technologies, but they highlight
important factors to be considered when
designing digital interventions to improve
tablet taking in this patient group. Failing
to consider these factors might affect
recruitment and retention to studies and
ultimately uptake of the technology itself.
Although purposive sampling was not
used when recruiting participants from the
two community centres (apart from age and
treatment with cardiovascular medica-
tions), the participants were diverse in
terms of their socioeconomic background
and their familiarity and access to technolo-
gy. However, the low number of participants,
limited geographical area, and problems
extrapolating our findings to the general pop-
ulation represent limitations28 that necessitate
a larger study in a wider geographical area.
For example, while most participants in the
present study were women, gender bias in
access to and use of technology of women
over men could not be ascertained and is
open to further investigation.
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Implications
Development and evaluation of the impact
of digital interventions are priorities for
healthcare providers on an international
scale. Numerous technologies exist to aid
patients with tablet taking and may addi-
tionally be used to monitor adherence.
Prior studies of the acceptability of tech-
nologies to improve tablet taking have
focused either on the potential physical
adverse effects of the technology15 or spe-
cific practicalities and perceptions, such as
usability.22
Our study identified a wide range of prac-
tical and perceptual barriers to and facilita-
tors of the use of technology. Simple digital
interventions to improve tablet taking in indi-
viduals aged >65 years hold potential, pro-
vided that they offer reminders and
monitoring and are based on a technology
that patients are already familiar with and
have easy access to. Minimising barriers
such as privacy concerns, discussing depen-
dency on technology,29 and having plans in
place for technology failure would improve
interest and consequently recruitment to
research studies.
The results presented here are informative
for healthcare practitioners, who are increas-
ingly involved in advising patients about
potential strategies to help with daily medi-
cine taking. Non-digital strategies, such as
multi-compartment compliance aids, are
available to support medication adherence,
optimise treatment benefits, and minimise
waste. However, there is limited evidence
to support their use.30 Interestingly, partici-
pants in our focus groups suggested that
those least familiar with technology (i.e.,
the older, more vulnerable part of the pop-
ulation) could be the ones who benefit the
most from digital interventions. They indi-
cated that the ISS is a promising approach
because this technology seemed simple
enough that, once set up, minimal techno-
logical understanding was needed to use it.
Compared with non-digital strategies, the
ISS was seen as offering the advantage of
real-time monitoring and identification of
problems before they become harmful.
Further research is needed to investigate
whether perceived barriers and facilitators
change over time as technology becomes
more commonly used in this patient group.
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